AC
Insider
AH Equity Partners Bio I, L.L.C.
10% ownerAH Equity Partners Bio I, L.L.C. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). Across 1 priced purchase filing, the average 21-session return was +20.8% from execution and -7.3% from disclosure (delay-adjusted; derived). The largest single filing was $8.0M of CAMP (727,272 sh across 2 lots, as filed), executed Oct 15 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+20.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-7.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$8.0M
shares × price, as filed
Last traded
Oct 15 2024
Filed Oct 17 2024
Median ADV $1.1M across their filed names
Open performance→Volume by month
Buys $8.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
CAMPRecent filings
CAMPPURCHASE
CAMP4 THERAPEUTICS CORPORATION
View filing →
$8.0M727,272 sh across 2 lots
Exec Oct 15 2024
Filed Oct 17 2024 · 5:30 PM ET